×
ADVERTISEMENT

AUGUST 22, 2019

CGRP Inhibitors Make Their Mark In Migraine Rx

By Gina Shaw

Boston—The advent of three new high-cost, monthly injectable medications for migraine has brought this highly prevalent chronic condition within the purview of specialty pharmacy, creating an imperative for specialty pharmacies to establish migraine management programs.

At the 2019 ASHP Summer Meetings and Exhibition, representatives from Shields Health Solutions shared their experience with rapid deployment of a migraine-focused monitoring tool and clinical management protocol